duloxetine hydrochloride has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa-Takata, T; Fujita, M; Isobe, A; Kimura, T; Kobayashi, E; Mabuchi, S; Matsuzaki, S; Otake, A; Sawada, K; Ueda, Y; Yoshino, K | 1 |
1 other study(ies) available for duloxetine hydrochloride and Cancer of Ovary
| Article | Year |
|---|---|
Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
Topics: Adult; Aged; Analgesics; Antineoplastic Agents, Phytogenic; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Thiophenes; Treatment Outcome | 2015 |